Join us for a discussion on the most urgent problems and opportunities facing diabetes today. Solvable Problems has a unique focus: newest treatment strategies, opportunities presented by new technology and digital health tools, and the future of diabetes care – all in light of COVID-19.
This year, Solvable Problems will highlight four extraordinary physician-researchers from England who are leading groundbreaking discoveries on the frontlines of several interrelated epidemics - including COVID-19, type 2 diabetes, and obesity. Their insights will serve the global community in more ways than one. Hear their take on how COVID-19 is revealing the hidden vulnerabilities in global healthcare delivery systems. Learn about how the city of Leicester, as part of Cities Changing Diabetes, is improving its urban environment by reducing food insecurity, increasing access to green spaces, and more, to empower people with diabetes. How does all of this relate to new therapies that are protecting against diabetes complications? And finally, how is diabetes data going to help people make therapeutic decisions, adapt to a new lifestyle, and even prosper as we move forward in an uncertain world?
We look forward to seeing you on September 22nd for our Solvable Problems in Diabetes event. Please spread the word and share this event with anyone interested in learning more about how COVID-19 is accelerating innovation in therapy, technology, and diabetes care. This year, Solvable Problems tickets will be complimentary thanks to the generous contributions of our sponsors. We welcome anyone interested in learning about the massive shifts and opportunities occurring in the world of diabetes. Join the conversation on Twitter with #diaTribeSolvableProb.
Submit questions for the panelists here.
This year's program will feature four excellent panelists who will participate in a captivating discussion moderated by The diaTribe Foundation's Kelly Close:
- Professor Partha Kar of NHS England
- Professor Melanie Davies of the University of Leicester
- Professor Kamlesh Khunti of the University of Leicester
- Professor Pratik Choudhary of the University of Leicester
Partha Kar is a National Specialty Advisor for Diabetes at NHS England and a co-lead of Diabetes GIRFT with NHS Improvement. Dr. Kar has been a Consultant in Diabetes & Endocrinology at Portsmouth Hospitals NHS Trust since 2008. He was the Clinical Director of Diabetes from 2009-2015 and part of a multiple national award-winning department. He has led and delivered on many initiatives including developing national guidelines during COVID-19, ensuring the availability of Freestyle Libre on the NHS, and improving hospital safety and mental health access for people with diabetes. He is the pioneer of the Super Six Diabetes Model which aims to deliver diabetes care differently and is recognized as one of the good examples of integrated care. An avid user of social media to engage with people with diabetes, he has been recognized as a "Social media Pioneer" by HSJ in 2014. He also writes a monthly blog for the BMJ, has a personal blog (“Sugar and Spice: Wish all things were nice”) and a podcast (“Sweet Talking”).
Melanie Davies is Professor of Diabetes Medicine at the University of Leicester and an Honorary Consultant Diabetologist at the University Hospitals of Leicester NHS Trust. She is based in the Diabetes Research Centre, University of Leicester and is also the Co-Director of the Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust. Professor Davies’ research interests include the causes, screening, prevention, self-management and treatment of type 2 diabetes mellitus. She is a National Institute for Health Research Senior Investigator Emeritus and Director of the NIHR Leicester Biomedical Research Centre. Professor Davies is the Principal Investigator on a number of large global studies in the field of diabetes, obesity, physical activity, sedentary behaviour and cardiovascular disease and co-chair of EASD/ADA’s Consensus Report on T2DM Management. Professor Davies has published over 550 original articles and has over £60M of grant funding. She was awarded the CBE (Commander of the Most Excellent Order of the British Empire) in the 2016 New Year’s Honour’s List for services to diabetes research.
Kamlesh Khunti is Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester, UK. He is Co-Director of the Leicester Diabetes Centre and leads a research group that is currently working on the early identification of, and interventions with, people who have cardiometabolic disease or are at increased risk of developing cardiometabolic diseases. His work has influenced national and international guidelines on the screening and management of people with diabetes. Professor Khunti is also Director of the UK National Institute for Health Research (NIHR) in Applied Research Collaborations (ARC) East Midlands, Director of Centre for BME Health and Director of The Real World Evidence Unit. He is a NIHR Senior Investigator and Principal Investigator on several major national and international studies. He has published over 800 publications. Professor Khunti is a Fellow of the Academy of Medical Sciences and is currently an advisor to the Department of Health. He is also Honorary Visiting Professorial Fellow with Department of General Practice, University of Melbourne.
Pratik Choudhary is a Professor of Diabetes at the University of Leicester, having joined there recently after 15 years at King’s College London. He has clinical and research interests into the mechanisms and management of hypoglycemia unawareness and the use of education and technology, especially new insulin pumps and continuous glucose monitors in the management of diabetes. He is work-package lead for the Hypo-RESOLVE consortium and within that is the principal investigator of a large multinational study evaluating the biological and psychosocial impacts of sensor detected hypoglycaemia. He is chair of the Diabetes Technology Network – UK, medical advisor to the Department of Transport, associate editor for Diabetic Medicine, and member of the EASD Postgraduate Education Committee.